GSK Investigational Site

Robbinsdale, Minnesota 55422

0 studies enrolling now · 8 studies all time

What they study most

Activity/Exercise Induced Bronchospasm, Acute Coronary Syndrome, Bronchospasm, Cancer, Chemotherapy-Induced Nausea and Vomiting, Lung Cancer, Non-Small Cell, Lung Cancer, Small Cell, Nausea and Vomiting, Neoplasms, Breast, Non-Small-Cell Lung Cancer, Small Cell Lung Cancer, Solid Tumor Cancer

Studies at this site

• Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer — Completed
• The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial — Completed
• The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC) — Completed
• A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise — Completed
• Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer — Completed
• Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer — Completed
• A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy — Withdrawn before enrolling
• Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer — Completed